1,268
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis

, , , , , , , , & show all
Pages 34-43 | Accepted 21 Aug 2015, Published online: 30 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sara Higa, Beth Devine, Vaishali Patel, Sarah Baradaran, Degang Wang & Aasthaa Bansal. (2019) Psoriasis treatment patterns: a retrospective claims study. Current Medical Research and Opinion 35:10, pages 1727-1733.
Read now
Mwangi J Murage, Vanita Tongbram, Steven R Feldman, William N Malatestinic, Cynthia J Larmore, Talia M Muram, Russel T Burge, Charles Bay, Nicole Johnson, Sarah Clifford & Andre B Araujo. (2018) Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review. Patient Preference and Adherence 12, pages 1483-1503.
Read now

Articles from other publishers (9)

Fiorenzo Santoleri, Ruggero Lasala, Paolo Abrate, Laura Pestrin, Enrico Pasut, Germana Modesti, Felice Musicco, Chiara Fulgenzio, Eva Zuzolo, Gabriella Pieri, Martina Roperti, Pietro Gazzola, Marco GamberaIsabella MartignoniValentina MontresorFrancesco De Vita, Francesca Guarino, Laura Grossi, Letizia Di Fabio, Cristina Roberti, Concetta Spoltore, Gabriella Tinari, Stefania De Rosa, Romina Giannini, Roberto Langella, Grazia Mingolla, Mariantonietta Piccoli & Alberto Costantini. (2023) ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy. Current Medical Research and Opinion, pages 1-13.
Crossref
Valentina Perrone, Serena Losi, Erica Filippi, Maurizio Mezzetti, Melania Dovizio, Diego Sangiorgi & Luca Degli Esposti. (2022) Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population. Rheumatology and Therapy 9:3, pages 875-890.
Crossref
Yu-Huei Huang, Chao-Hsiun Tang, Choo Hua Goh, Chia-Li Chang, Hong Qiu, Ya-Wen Yang, Carine Saadoun, Chia-Ling Chang & Yanfang Liu. (2022) Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study. Frontiers in Pharmacology 13.
Crossref
Kirk Geale, Ingrid Lindberg, Emma C Paulsson, E Christina M Wennerström, Anna Tjärnlund, Wim Noel, Dana Enkusson & Elke Theander. (2020) Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden. Rheumatology Advances in Practice 4:2.
Crossref
Steven R. Feldman, Jashin J. Wu, April W. Armstrong, Mark Lebwohl, Abby A. Jacobson, Melissa Lingohr-Smith & Jay Lin. (2019) Evaluating Costs of Biologic Drugs for the Treatment of Moderate-to-Severe Psoriasis in the United States. Journal of Psoriasis and Psoriatic Arthritis 4:3, pages 133-142.
Crossref
Jeffrey R. Curtis. (2019) The promise and perils of ‘Big Data’: focus on spondyloarthritis. Current Opinion in Rheumatology 31:4, pages 355-361.
Crossref
Seina LeeLin XieYuexi WangNeel VaidyaOnur Baser. (2018) Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population. Journal of Managed Care & Specialty Pharmacy 24:7, pages 654-663.
Crossref
Louis Bessette, Majed Khraishi, Alan J. Kivitz, Arunan Kaliyaperumal, Rama Grantab, Melanie Poulin-Costello, Maya Isaila & David Collier. (2017) Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment. Rheumatology and Therapy 4:2, pages 391-404.
Crossref
Dillon Kersh, Roselyn Kellen & Sharon Rose. (2016) The Annual Economic Burden of Psoriasis. Journal of Psoriasis and Psoriatic Arthritis 1:3, pages 112-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.